Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orexigen
Orexigen
Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside
Wall St 24/7
Mon, 01/27/14 - 09:21 am
Avanir
BioDelivery Sciences
Conatus Pharmaceuticals
Geron
Halozyme
Neurocrine
Orexigen
Arena Investors Await Strong Sales Data
Seeking Alpha
Mon, 01/27/14 - 08:17 am
Arena Pharmaceuticals
Belviq
Eisai
Orexigen
Vivus
Orexigen Receives Good News From FDA
Seeking Alpha
Tue, 01/7/14 - 06:53 pm
Orexigen
obesity
Contrave
FDA
Obesity Stocks Focus on Approvals As Arena Pharmaceuticals Goes Global
TheStreet.com
Mon, 01/6/14 - 07:26 pm
drug approvals
Arena Pharmaceuticals
obesity
GSK
Orexigen
Belviq
Eisai
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals
Vivus Scores Insurance Win
Seeking Alpha
Thu, 01/2/14 - 12:38 pm
Vivus
Orexigen
obesity
insurance
Caremark
Arena Pharmaceuticals
Qsymia
Orexigen Resubmits Contrave New Drug Application
Yahoo
Wed, 12/11/13 - 11:25 am
Orexigen
FDA
obesity
Contrave
Will These Drugmakers Profit From Patient Weight Loss?
Motley Fool
Wed, 12/4/13 - 03:47 pm
obesity
Victoza
Novo Nordisk
Contrave
Orexigen
Vivus
Qsymia
[video] A Chart You Should See: Investors Put Greater Weight Behind Orexigen Than Arena, Vivus
TheStreet.com
Mon, 11/25/13 - 12:54 pm
Orexigen
obesity
Contrave
Vivus
Arena Pharmaceuticals
Orexigen rises after obesity drug doesn't increase heart risk in study
The Fly on the Wall
Mon, 11/25/13 - 11:45 am
Orexigen
obesity
Contrave
Orexigen Weight-Loss Pill Passes Safety Hurdle
TheStreet.com
Mon, 11/25/13 - 10:35 am
Orexigen
obesity
Contrave
FDA
Takeda
Can Orexigen Therapeutics Catch Up With Arena Pharmaceuticals and VIVUS?
Motley Fool
Mon, 11/11/13 - 10:19 am
Arena Pharmaceuticals
Vivus
obesity
Orexigen
Contrave
Belviq
Qsymia
Sanofi To Manufacture Orexigen’s Contrave
Contract Pharma
Fri, 11/8/13 - 09:36 am
Sanofi
drug manufacturing
Contrave
Orexigen
[video]Can This Obesity-Drug Maker Beat Arena and VIVUS in Europe?
Motley Fool
Mon, 10/7/13 - 09:12 am
obesity
Europe
Vivus
Arena Pharmaceuticals
Belviq
Qsymia
Contrave
Orexigen
Orexigen obesity drug Contrave filed in Europe
Pharma Times, UK
Fri, 10/4/13 - 10:16 am
Orexigen
Europe
Contrave
obesity
Obesity drug makers jockey for position as analysts praise Vivus
Marketwatch
Thu, 10/3/13 - 05:29 pm
obesity
Vivus
Belviq
Arena Pharmaceuticals
Contrave
Orexigen
Qsymia
Third Obesity Drug Moves Closer to FDA Approval
Motley Fool
Thu, 08/29/13 - 05:05 pm
obesity
FDA
Orexigen
Contrave
Belviq
Qsymia
Vivus
Arena Pharmaceuticals
Orexigen Readies New Drug Application
Seeking Alpha
Tue, 08/27/13 - 10:56 am
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Belviq
Qsymia
Vivus
Who Will Be the Winner in the Fight Against Obesity?
Motley Fool
Thu, 08/22/13 - 05:37 pm
obesity
Vivus
Qsymia
Belviq
Eisai
Arena Pharmaceuticals
Contrave
Orexigen
Report Outlines Arena's European Prospects
Seeking Alpha
Wed, 08/21/13 - 09:47 am
Arena Pharmaceuticals
Belviq
Orexigen
Europe
Eisai
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »